Search Results Search Sort by RelevanceMost Recent State of the Art and Science Mar 2021 Piloting and Scaling a Good Health Equity Evidence Base From Big Data Stephen Lockhart, MD, PhD One health system’s development and validation of inequity measures across patient groups demonstrates an approach that could be nationally scalable. AMA J Ethics. 2021;23(3):E252-257. doi: 10.1001/amajethics.2021.252. Medicine and Society Mar 2021 How Should Health Professionalism Be Redefined to Address Health Equity? Candice Chen, MD, MPH and Andrea Anderson, MD The opioid crisis, maternal death, and COVID-19 underscore trust as foundational to public health and call for redefinition of what it means to be a US clinician. AMA J Ethics. 2021;23(3):E265-270. doi: 10.1001/amajethics.2021.265. History of Medicine Mar 2021 How Should We Respond to Racist Legacies in Health Professions Education Originating in the Flexner Report? Terri Laws, PhD The Flexner Report marginalized schools that produce more than their fair share of physicians confronting inequities in US responses to COVID-19. AMA J Ethics. 2021;23(3):E271-275. doi: 10.1001/amajethics.2021.271. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607. Policy Forum Aug 2021 How Does Cost-Effectiveness Analysis Inform Health Care Decisions? David D. Kim, PhD and Anirban Basu, PhD CEA has been increasingly used to inform public and private organizations’ reimbursement decisions, benefit designs, and price negotiations worldwide. AMA J Ethics. 2021;23(8):E639-647. doi: 10.1001/amajethics.2021.639. Podcast Aug 2021 Author Interview: How Does Cost-Effectiveness Analysis Inform Health Care Decisions? Drs David D. Kim and Anirban Basu join Ethics Talk to discuss their article: "How Does Cost-Effectiveness Analysis Inform Health Care Decisions?" Health Law Oct 2020 Effects of Substance Use Disorder Criminalization on American Indian Pregnant Individuals Rachel Simon, MD, Jennifer Giroux, MD, MPH, and Julie Chor, MD, MPH Clinicians must advocate for decriminalization of SUDs during pregnancy and for improving access to comprehensive, evidence-based care. AMA J Ethics. 2020;22(10):E862-867. doi: 10.1001/amajethics.2020.862. Medicine and Society Oct 2020 Racialization as a Barrier to Achieving Health Equity for Native Americans Vikas Gampa, MD, Kenneth Bernard, MD, MBA, and Michael J. Oldani, PhD, MS “Race” is a product of European-American views of phenotypic and cultural differences and continues to influence Native health decision making. AMA J Ethics. 2020;22(10):E874-881. doi: 10.1001/amajethics.2020.874. Policy Forum Aug 2020 Advocacy and Action to End the Opioid Epidemic by the AMA Opioid Task Force Patrice A. Harris, MD, MA and Bobby Mukkamala, MD Six recommendations focus on specific actions to help reverse the nation’s opioid epidemic. AMA J Ethics. 2020;22(8):E718-722. doi: 10.1001/amajethics.2020.718. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
State of the Art and Science Mar 2021 Piloting and Scaling a Good Health Equity Evidence Base From Big Data Stephen Lockhart, MD, PhD One health system’s development and validation of inequity measures across patient groups demonstrates an approach that could be nationally scalable. AMA J Ethics. 2021;23(3):E252-257. doi: 10.1001/amajethics.2021.252.
Medicine and Society Mar 2021 How Should Health Professionalism Be Redefined to Address Health Equity? Candice Chen, MD, MPH and Andrea Anderson, MD The opioid crisis, maternal death, and COVID-19 underscore trust as foundational to public health and call for redefinition of what it means to be a US clinician. AMA J Ethics. 2021;23(3):E265-270. doi: 10.1001/amajethics.2021.265.
History of Medicine Mar 2021 How Should We Respond to Racist Legacies in Health Professions Education Originating in the Flexner Report? Terri Laws, PhD The Flexner Report marginalized schools that produce more than their fair share of physicians confronting inequities in US responses to COVID-19. AMA J Ethics. 2021;23(3):E271-275. doi: 10.1001/amajethics.2021.271.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607.
Policy Forum Aug 2021 How Does Cost-Effectiveness Analysis Inform Health Care Decisions? David D. Kim, PhD and Anirban Basu, PhD CEA has been increasingly used to inform public and private organizations’ reimbursement decisions, benefit designs, and price negotiations worldwide. AMA J Ethics. 2021;23(8):E639-647. doi: 10.1001/amajethics.2021.639.
Podcast Aug 2021 Author Interview: How Does Cost-Effectiveness Analysis Inform Health Care Decisions? Drs David D. Kim and Anirban Basu join Ethics Talk to discuss their article: "How Does Cost-Effectiveness Analysis Inform Health Care Decisions?"
Health Law Oct 2020 Effects of Substance Use Disorder Criminalization on American Indian Pregnant Individuals Rachel Simon, MD, Jennifer Giroux, MD, MPH, and Julie Chor, MD, MPH Clinicians must advocate for decriminalization of SUDs during pregnancy and for improving access to comprehensive, evidence-based care. AMA J Ethics. 2020;22(10):E862-867. doi: 10.1001/amajethics.2020.862.
Medicine and Society Oct 2020 Racialization as a Barrier to Achieving Health Equity for Native Americans Vikas Gampa, MD, Kenneth Bernard, MD, MBA, and Michael J. Oldani, PhD, MS “Race” is a product of European-American views of phenotypic and cultural differences and continues to influence Native health decision making. AMA J Ethics. 2020;22(10):E874-881. doi: 10.1001/amajethics.2020.874.
Policy Forum Aug 2020 Advocacy and Action to End the Opioid Epidemic by the AMA Opioid Task Force Patrice A. Harris, MD, MA and Bobby Mukkamala, MD Six recommendations focus on specific actions to help reverse the nation’s opioid epidemic. AMA J Ethics. 2020;22(8):E718-722. doi: 10.1001/amajethics.2020.718.